MDS AZA 003

Trial description
A phase 3, multicentre, randomized, double-blind study to compare with efficacy and safety of oral azacitidine plus best supportive care versus placebo plus best supportive care in subjects with red blood cell transfusion-dependent anemia and thrombocytopenia due to IPSS lower-risk myelodysplatic syndromes
Contact name
Dr Theodora Foukaneli
Trial start date
Monday, October 27, 2014
Trial end date
Friday, October 30, 2020
Trial tumour type
Haematological
Show on Radiotherapy
No